Clinical Trials Directory

Trials / Unknown

UnknownNCT05521035

Risk and Incidence of Aortic Graft and Endograft Infection With BSI

Risk and Incidence of Aortic Graft and Endograft Infection in Patients With Bloodstream Infection, a Population Based Study in South Sweden

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Lund University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

What is the risk of aortic vascular graft and endograft infection in patients with aortic vascular graft/endograft and bloodstream infection?

Detailed description

All patients with previous aortic vascular graft and endograft surgery between years 2010 and 2021 in four regions of south Sweden (Skåne, Halland, Kronoberg and Blekinge) will be included in the study. These patients will be evaluated for bloodstream infection (BSI) or not. For all patients with BSI, the risk of aortic vascular graft and endograft infection will be investigated. Aortic vascular graft and endograft infection will be determined by usage of the MAGIC-criteria. Risk factors for developing aortic vascular graft and endograft infection will be investigated, and if possible used to construct a risk score. This risk score could be used by clinicians to determine if bacteremic patients with aortic vascular grafts or endografts should be evaluated for aortic vascular graft and endograft infection.

Conditions

Timeline

Start date
2022-09-01
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2022-08-30
Last updated
2023-12-14

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05521035. Inclusion in this directory is not an endorsement.

Risk and Incidence of Aortic Graft and Endograft Infection With BSI (NCT05521035) · Clinical Trials Directory